Elizabeth A. Lunney

Statistical method on nonrandom clustering with application to somatic mutations in cancer

Jingjing Ye, Paul A. Rejto, Adam Pavlícek, 2010, BMC Bioinformatics.

Prediction of specificity-determining residues for small-molecule kinase inhibitors

Elizabeth A. Lunney, Daniel R. Caffrey, Deborah J. Moshinsky, 2008, BMC Bioinformatics.

Scaffold mining of kinase hinge binders in crystal structure database

Li Xing, Elizabeth A. Lunney, Brajesh Rai, 2013, Journal of Computer-Aided Molecular Design.

HIV Protease Inhibitors Possessing a Novel, High-Affinity, and Achiral P1'/P2' Ligand with a Unique Pattern of in Vitro Resistance. Importance of a Conformationally-Restricted Template in the Design of Enzyme Inhibitors

Donna Ferguson, Elizabeth A. Lunney, Barbra H. Stewart, 1995 .

Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease Inhibitors

James B. Dunbar, Daniel F. Ortwine, Donna Ferguson, 1994 .

KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

Yan Zhang, Mark R. Emmett, Alan G. Marshall, 2009, Proceedings of the National Academy of Sciences.

A topliss tree analysis of the HIV-protease inhibitory activity of 6-phenyl-4-hydroxy-pyran-2-ones

Donna Ferguson, Elizabeth A. Lunney, C. J. Blankley, 1996 .